Alvotech (ALVO)
USD 8.22
(3.53%)
USD 8.22
(3.53%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.07 Billion USD | 33.58% |
| 2022 | 805.1 Million USD | 53.92% |
| 2021 | 523.05 Million USD | -22.72% |
| 2020 | 676.84 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.18 Billion USD | 8.05% |
| 2024 Q1 | 1.09 Billion USD | 2.27% |
| 2023 Q2 | 904.03 Million USD | 8.17% |
| 2023 FY | 1.07 Billion USD | 33.58% |
| 2023 Q4 | 1.07 Billion USD | 5.95% |
| 2023 Q3 | 1.01 Billion USD | 12.28% |
| 2023 Q1 | 835.79 Million USD | 3.81% |
| 2022 Q1 | 119.15 Thousand USD | -99.98% |
| 2022 FY | 805.1 Million USD | 53.92% |
| 2022 Q4 | 805.1 Million USD | 26.44% |
| 2022 Q3 | 636.75 Million USD | -6.58% |
| 2022 Q2 | 681.6 Million USD | 571916.38% |
| 2021 Q3 | 119.15 Thousand USD | 0.0% |
| 2021 Q4 | 523.05 Million USD | 438852.16% |
| 2021 Q2 | 119.15 Thousand USD | 0.0% |
| 2021 Q1 | 119.15 Thousand USD | 0.0% |
| 2021 FY | 523.05 Million USD | -22.72% |
| 2020 Q2 | 141.97 Million USD | 0.0% |
| 2020 Q1 | 141.97 Million USD | 0.0% |
| 2020 Q4 | 119.15 Thousand USD | -99.92% |
| 2020 Q3 | 141.97 Million USD | 0.0% |
| 2020 FY | 676.84 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 540.94 Million USD | -98.813% |
| Theratechnologies Inc. | 58.96 Million USD | -1723.826% |
| Safety Shot Inc | 1.54 Million USD | -69331.378% |
| Cosmos Health Inc. | 12.42 Million USD | -8556.456% |
| Cronos Group Inc. | 2.53 Million USD | -42242.53% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | -50.303% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | -2860.862% |
| Organogenesis Holdings Inc. | 119.35 Million USD | -801.102% |
| Universe Pharmaceuticals INC | 5.48 Million USD | -19516.646% |
| ProPhase Labs, Inc. | 21.38 Million USD | -4930.281% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -176787.171% |
| Dynavax Technologies Corporation | 256.91 Million USD | -318.612% |
| Radius Health, Inc. | 365.31 Million USD | -194.398% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -40522.938% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -163419.207% |
| Alpha Teknova, Inc. | 30.45 Million USD | -3431.007% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | -6249.475% |
| SCYNEXIS, Inc. | 15.08 Million USD | -7031.79% |
| Harrow Health, Inc. | 190.5 Million USD | -464.547% |
| Biofrontera Inc. | 5.39 Million USD | -19819.874% |
| DURECT Corporation | 20.74 Million USD | -5084.007% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | -2489.819% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | -241.065% |
| OptiNose, Inc. | 131.74 Million USD | -716.305% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -91585.294% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | -988.294% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | -5735.933% |
| SIGA Technologies, Inc. | 1.46 Million USD | -73360.887% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | -725.003% |
| Shineco, Inc. | 29.65 Million USD | -3526.443% |
| Phibro Animal Health Corporation | 525.45 Million USD | -104.673% |
| Procaps Group S.A. | 285.93 Million USD | -276.125% |
| TherapeuticsMD, Inc. | 8 Million USD | -13335.028% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -1798141.009% |
| Viatris Inc. | 18.12 Billion USD | 94.066% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -163419.207% |
| Rockwell Medical, Inc. | 13.43 Million USD | -7902.634% |
| Incannex Healthcare Limited | 373 Thousand USD | -288230.831% |
| Aytu BioPharma, Inc. | 15.12 Million USD | -7008.692% |
| Tilray Brands, Inc. | 387.31 Million USD | -177.673% |
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | -59.499% |
| PetIQ, Inc. | 468.3 Million USD | -129.654% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | -151.044% |
| Journey Medical Corporation | 17.73 Million USD | -5965.843% |
| Alimera Sciences, Inc. | 67.39 Million USD | -1495.682% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | -12894.166% |
| Assertio Holdings, Inc. | 40.91 Million USD | -2528.75% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -98776.522% |
| Embecta Corp. | 1.63 Billion USD | 34.362% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -104000.124% |
| Procaps Group, S.A. | 285.93 Million USD | -276.125% |
| PainReform Ltd. | 86 Thousand USD | -1250451.163% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | -2939.436% |
| Hempacco Co., Inc. | 13.72 Million USD | -7736.159% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 586.04 Million USD | -83.514% |
| Alvotech | 1.07 Billion USD | 0.0% |
| Lantheus Holdings, Inc. | 616.94 Million USD | -74.322% |
| Kamada Ltd. | 8.74 Million USD | -12192.555% |
| Indivior PLC | 281.6 Million USD | -281.913% |
| Currenc Group, Inc. | 31.94 Million USD | -3266.786% |
| Evoke Pharma, Inc. | 5 Million USD | -21409.48% |
| Flora Growth Corp. | 3.67 Million USD | -29188.508% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -104000.124% |
| Evolus, Inc. | 126.54 Million USD | -749.868% |
| HUTCHMED (China) Limited | 86.13 Million USD | -1148.649% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | -72.451% |
| Akanda Corp. | 3.99 Million USD | -26794.979% |